Latest Russell E. Ware Stories
More public awareness and education about sickle cell disease, an inherited disease that affects the blood system, is critically important.
A recently announced sickle cell disease program in Luanda, Angola, is making progress in its objective to establish the Central African nation's first comprehensive initiatives to fight the disease.
As researchers continue to study the use of hydroxyurea as a treatment for sickle cell disease, there is more evidence to validate that it is safe and effective for children with the disease, said an expert pediatric hematologist from Baylor College of Medicine.
Texas Children's Hospital and Baylor College of Medicine today announced the creation of the Texas Children's Center for Global Health and the appointment of renowned physician-scientist Dr. Russell E. Ware as director.
St. Jude Children's Research Hospital will lead a national Phase III clinical trial to investigate whether a new combination treatment can prevent a secondary stroke in children with sickle cell anemia (SCA) and eliminate the need for nightly injections with a drug that reduces iron overload in these patients.